To evaluate whether changes in the frequency of regulatory B cell (Breg) populations are associated with clinical improvement of the disease, we analyzed the frequency of PD-L1-expressing peripheral B cell subsets in patients with RA under different treatments, and their functional activity on T cell response. This evidence concerns the gene CD274 and rheumatoid arthritis.